Wedbush Has Negative Forecast for Ardelyx FY2029 Earnings
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Equities research analysts at Wedbush lowered their FY2029 earnings estimates for shares of Ardelyx in a report issued on Friday, February 21st. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings per share of $0.88 for the year, down from their prior estimate of […]
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Equities research analysts at Wedbush lowered their FY2029 earnings estimates for shares of Ardelyx in a report issued on Friday, February 21st. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings per share of $0.88 for the year, down from their prior estimate of […]
